REFRACTORY LYMPHOBLASTIC LYMPHOMA
Clinical trials for REFRACTORY LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for REFRACTORY LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to beat back tough blood cancers
Disease control Recruiting nowThis study tests a mix of six chemotherapy drugs in people whose acute lymphoblastic leukemia, lymphoblastic lymphoma, or related blood cancers have returned or stopped responding to treatment. The goal is to see if this combination can shrink or control the cancer and to check f…
Matched conditions: REFRACTORY LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
Engineered immune cells take on tough blood cancers in new trial
Disease control Recruiting nowThis early-phase trial tests a new type of CAR T-cell therapy for people with certain blood cancers (like lymphoma, leukemia) that have returned or not responded to standard treatments. The therapy uses a patient's own immune cells, modified in a lab to target three cancer marker…
Matched conditions: REFRACTORY LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:52 UTC